نگاهی بر مانکی پاکس ویروس، هشدار جهانی و تکنیکهای  شناسایی آن

1.Peter OJ, Kumar S, Kumari N, Oguntolu FA, Oshinubi K, Musa R. Transmission dynamics of Monkeypox virus: a mathematical modelling approach. Model Earth Syst Environ 2022;8:3423–34.

2.Le´on-Figueroa DA, Bonilla-Aldana DK, Pachar M, Romaní L, Salda˜na-Cumpa HM, Anchay-Zuloeta C, et al. The never-ending global emergence of viral zoonoses after COVID-19? The rising concern of monkeypox in Europe, North America and beyond. Trav Med Infect Dis 2022;49:102362.

3.Mileto D, Riva A, Cutrera M, Moschese D, Mancon A, Meroni L, et al. New challenges in human monkeypox outside Africa: a review and case report from Italy. Trav Med Infect Dis 2022;49:102386.

4.Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses 2020;12:1257.

5.Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Neglected Trop Dis 2022;16:e0010141.

6.Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin 2019;33:1027–43.

7.Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Neglected Trop Dis 2019;13:e0007791.

8.Reynolds MG, Doty JB, McCollum AM, Olson VA, Nakazawa Y. Monkeypox reemergence in Africa: a call to expand the concept and practice of One Health. Expert Rev Anti Infect Ther 2019;17:129–39.

9.Vaughan A, Aarons E, Astbury J, Brooks T, Chand M, Flegg P, et al. Human-to-Human transmission of monkeypox virus, United Kingdom, October 2018. Emerg Infect Dis 2020;26:782–5.

10. Zambrano PG, Acosta-Espa˜na JD, Mosquera Moyano F, Altamirano Jara JB. Sexually or intimately transmitted infections: a look at the current outbreak of monkeypox in 2022. Trav Med Infect Dis 2022;49:102383.

11.Durski KN, McCollum AM, Nakazawa Y, Petersen BW, Reynolds MG, Briand S, etal. Emergence of monkeypox — west and central Africa, 1970–2017. MMWR Morb Mortal Wkly Rep 2018;67:306–10.

12.Puca E, Shapo L. For how long can monkeypox reach the Balkan region? Trav Med Infect Dis 2022;49:102382. https://doi.org/10.1016/j.tmaid.2022.102382.

13.Farahat RA, Ali I, Al-Ahdal T, Benmelouka AY, Albakri K, El-Sakka AA, et al. Monkeypox and human transmission: are we on the verge of another pandemic? Trav Med Infect Dis 2022;49:102387.

14.Isidro J, Borges V, Pinto M, Sobral D, Santos JD, Nunes A, et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat Med 2022;28:1569–72.

15.Nuzzo JB, Borio LL, Gostin LO. The WHO declaration of monkeypox as a global public health emergency. JAMA 2022;328:615–7

16.Giovanetti, M.; Cella, E.; Moretti, S.; Scarpa, F.; Ciccozzi, A.; Slavov, S.N.; Benedetti, F.; Zella, D.; Ceccarelli, G.; Ciccozzi, M.; et al. Monitoring monkeypox: Safeguarding global health through rapid response and global surveillance. Pathogens 2023, 12, 1153. [CrossRef]

17.2022 Monkeypox Outbreak: Global Trends; World Health Organization; Geneva, Switzerland, 2022. Available online: https: //worldhealthorg.shinyapps.io/mpx_global/ (accessed on 27 June 2023).

18.Gessain, A.; Nakoune, E.; Yazdanpanah, Y. Monkeypox. N. Engl. J. Med. 2022, 387, 1783–1793. [CrossRef] [PubMed] [19]. Li, Y.; Zhao, H.;Wilkins, K.; Hughes, C.; Damon, I.K. Real-time PCR assays for the specific detection of monkeypox virusWest African and Congo Basin strain DNA. J. Virol. Methods 2010, 169, 223–

227. [CrossRef] [PubMed]

20.Laboratory Testing for the Monkeypox Virus: Interim Guidance. Available online: https://iris.who.int/handle/10665/354488 (accessed on 5 December 2022).

21.Scarpa, F.; Sanna, D.; Azzena, I.; Cossu, P.; Locci, C.; Angeletti, S.; Maruotti, A.; Ceccarelli, G.; Casu, M.; Fiori, P.L.; et al. Genetic Variability of the Monkeypox Virus Clade IIb B.1. J. Clin. Med. 2022, 11, 6388. [CrossRef]

22.Gentile, M.; Gelderblom, H.R. Rapid viral diagnosis: Role of electron microscopy. New Microbiol. 2005, 28, 1–12. [PubMed]

23.Müller, M.; Ingold-Heppner, B.; Stocker, H.; Heppner, F.L.; Dittmayer, C.; Laue, M. Electron microscopy images of monkeypox virus infection in 24-year-old man. Lancet 2022, 400, 1618. [CrossRef]

24.Erez, N.; Achdout, H.; Milrot, E.; Schwartz, Y.; Wiener-Well, Y.; Paran, N.; Politi,B.; Tamir, H.; Israely, T.; Weiss, S.; et al. Diagnosis of imported monkeypox, Israel, 2018. Emerg. Infect. Dis. 2019, 25, 980. [CrossRef]

25.Hutson, C.L.; Kondas, A.V.; Mauldin, M.R.; Doty, J.B.; Grossi, I.M.; Morgan, C.N.; Ostergaard, S.D.; Hughes, C.M.; Nakazawa, Y.;Kling, C.; et al. Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus. animal model. MSphere 2021, 6, 10–1128. [CrossRef]

26.Gilchuk, I.; Gilchuk, P.; Sapparapu, G.; Lampley, R.; Singh, V.; Kose, N.; Blum, D.L.; Hughes, L.J.; Satheshkumar, P.S.; Townsend, M.B.; et al. Cross-neutralizing and protective human antibody specificities to poxvirus infections. Cell 2016, 167, 684–694. [CrossRef] [PubMed]

27.Weaver, J.R.; Isaacs, S.N. Monkeypox virus and insights into its immunomodulatory proteins. Immunol. Rev. 2008, 225, 96–113. [CrossRef] [PubMed

28.Dubois, M.E.; Hammarlund, E.; Slifka, M.K. Optimization of peptide-based ELISA for serological diagnostics: A retrospective study of human monkeypox infection. Vector-Borne Zoonotic Dis. 2012, 12, 400–409. [CrossRef] [PubMed]

29.Farlow, J.; Ichou, M.A.; Huggins, J.; Ibrahim, S. Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus. Virol. J. 2010, 7, 110. [CrossRef] [PubMed]

30.Vazquez, C.; Fonseca, V.; de la Fuente, A.G.; Gonzalez, S.; Fleitas, F.; Lima, M.; Guimarães, N.R.; Iani, F.C.; Rojas, A.; Alfonso, T.; et al. Exploring the Genomic Dynamics of the Monkeypox Epidemic in Paraguay. Viruses 2024, 16, 83. [CrossRef] [PubMed]

31.Nolen, L.D.; Osadebe, L.; Katomba, J.; Likofata, J.; Mukadi, D.; Monroe, B.; Doty, J.; Malekani, J.; Kabamba, J.; Bomponda, P.L.; et al. Introduction of monkeypox into a community and household: Risk factors and zoonotic reservoirs in the Democratic Republic of the Congo. Am. J. Trop. Med. Hyg. 2015, 93, 410. [CrossRef] [PubMed]

32.Li, E.; Guo, X.; Hong, D.; Gong, Q.; Xie,W.; Li, T.; Wang, J.; Chuai, X.; Chiu, S. Duration of humoral immunity from smallpox

cination and its cross-reaction with Mpox virus. Signal Transduct. Target. Ther. 2023, 8, 350. [CrossRef] [PubMed]

33.McQuiston, J.H. The CDC Domestic Mpox Response—United States, 2022–2023; U.S. Department of Health & Human Services: Washington, DC, USA, 2023; p. 72.

34.Branda, F.; Pierini, M.; Mazzoli, S. Monkeypox: EpiMPX surveillance system and open data with a special focus on European and Italian epidemic. J. Clin. Virol. Plus 2022, 2, 100114. [CrossRef] [PubMed]

35.Karesh, W.B.; Dobson, A.; Lloyd-Smith, J.O.; Lubroth, J.; Dixon, M.A.; Bennett, M.; Aldrich, S.; Harrington, T.; Formenty, P.; Loh,E.H.; et al. Ecology of zoonoses: Natural and unnatural histories. Lancet 2012, 380, 1936–1945. [CrossRef] [PubMed]

36.World Health Organization. Managing Epidemics: Key Facts about Major Deadly Diseases; World Health Organization: Geneve, Switzerland, 2018.

37.Williams, B.A.; Jones, C.H.; Welch, V.; True, J.M. Outlook of pandemic preparedness in a post-COVID-19 world. NPJ Vaccines 2023, 8, 178. [CrossRef]

38.Zhang, Y.; Li, Z.; Zhao, Y. Multi-mitigation strategies in medical supplies for epidemic outbreaks. Socio-Econ. Plan. Sci. 2023, 87,101516. [CrossRef]

39.Mutch, C.P.; Tiernan, J.; Koch, O.; Poller, B. The PATH to PPE Mastery-Programme for Assessment and Training in HCID (High Consequence Infectious Diseases) PPE (Personal Protective Equipment), Mastery. Infect. Prev. Pract. 2023, 5, 100308. [CrossRef] [PubMed]

40.Ugwu, S.E.; Abolade, S.A.; Ofeh, A.S.; Awoyinka, T.B.; Okolo, B.O.; Ayeni, E.T.; Kolawole, E.O. Knowledge, attitude, and perception of monkeypox among medical/health students across media space in Nigeria. Int. J. Community Med. Public Health 2022, 9, 4391. [CrossRef]

41.Ben-Enukora, C.; Oyero, O.; Okorie, N.; Odiboh, O.O.; Adeyeye, B.K. Analysis of 2017 risk communication on Human Monkey Pox outbreak in Nigeria’s News Media. Int. J. Educ. Inf. Technol. 2020, 14, 69–75. [CrossRef]

42.Roess, A.A.; Monroe, B.P.; Kinzoni, E.A.; Gallagher, S.; Ibata, S.R.; Badinga, N.; Molouania, T.M.; Mabola, F.S.; Mombouli, J.V.; Carroll, D.S.; et al. Assessing the effectiveness of a community intervention for monkeypox prevention in the Congo basin. PLoS Neglected Trop. Dis. 2011, 5, e1356. [CrossRef] [PubMed]

43.Ghazy, R.M.; Yazbek, S.; Gebreal, A.; Hussein, M.; Addai, S.A.; Mensah, E.; Sarfo, M.; Kofi, A.; Al-Ahdal, T.; Eshun, G. Monkeypox

vaccine acceptance among Ghanaians: A call for action. Vaccines 2023, 11, 240. [CrossRef]

44.Gesser-Edelsburg, A.; Shir-Raz, Y.; Walter, N.; Mordini, E.; Dimitriou, D.; James, J.J.; Green, M.S. The public sphere in emerging infectious disease communication: Recipient or active and vocal partner? Disaster Med. Public Health Prep. 2015, 9, 447–458.[CrossRef] [PubMed]

45.Hoff, N.A. Utilization Assessment of Infectious Disease Surveillance Data to Enhance Methods for Better Understanding Disease Occurrence, Trends and Gaps in Disease Reporting in a Resource Limited Setting: Monkeypox in the Democratic Republic of Congo; University of

California: Los Angeles, CA, USA, 2014.

46.Fitzmaurice, A.G.; Mahar, M.; Moriarty, L.F.; Bartee, M.; Hirai, M.; Li, W.; Gerber, A.R.; Tappero, J.W.; Bunnell, R.; Group, G.I. Contributions of the US Centers for Disease Control and Prevention in implementing the Global Health Security Agenda in 17 partner countries. Emerg. Infect. Dis. 2017, 23, S15. [CrossRef] [PubMed]

47.Naidoo, D.; Ihekweazu, C. Nigeria’s efforts to strengthen laboratory diagnostics-why access to reliable and affordable diagnostics is key to building resilient laboratory systems. Afr. J. Lab. Med. 2020, 9, 1019. [CrossRef] [PubMed]

48.White, L.A.; Forester, J.D.; Craft, M.E. Disease outbreak thresholds emerge from interactions between movement behavior,

landscape structure, and epidemiology. Proc. Natl. Acad. Sci. USA 2018, 115, 7374–7379. [CrossRef]

49.Francesco Branda, Chiara Romano, Massimo Ciccozzi, Marta Giovanetti, Fabio Scarpa, AClin. Med. 2024, 13, 2234. https://doi.org/10.3390/jcm13082234. An Overview of Pathogenesis, Diagnosis, and Public Health Implications.